Pipeline

Full Pipeline

Albumedix’ albumin-based technologies are both clinically and commercially validated in a number of albumin-enabled pharmaceutical programs by partners. These programs include all from preclinical candidates to marketed products spanning a wide range of therapeutic indications, demonstrating the value and applicability of Albumedix’ recombinant human albumin products and technologies.

Veltis® pipeline

Albumedix’s Veltis® drug delivery platform is used in marketed and late-stage clinical drug candidates. Through our partners, Veltis® has been both clinically and commercially validated for its superior performance in optimizing drug dosing across a range of indications.

In addition to the candidates listed in the below pipeline, Veltis® is currently being evaluated by several biotech and pharmaceutical companies, with a number in late-stage feasibility testing.

 

Recombumin® pipeline

Similar to our partnered Veltis® drug pipeline, Albumedix’s Recombumin® recombinant albumin products are successfully being used by drug and vaccine developers in more than 10 clinical programs worldwide. This serves as additional validation to the long track-record of superior performance and safety already demonstrated with Recombumin®.

 

Additionally, Recombumin® is used in several marketed as well as clinical-stage medical device products and cell therapies globally.

SEND ME MORE...

Send now

Brochures

articles

Albumedix

Next event

The International yeast meeting

Meet up with Albumedix at the 2017 The International yeast meeting